#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2329370	F	Ratio of cidofovir IC50 to compound IC50 for Vaccinia virus WR	Vaccinia virus	2		organism-based format	Scientific Literature
2.	ALA2329371	F	Ratio of ribavirin TCID50 to compound TCID50 for wild type Measles virus mWTFb	Measles morbillivirus	1		organism-based format	Scientific Literature
3.	ALA2329372	F	Antiviral activity against wild type Measles virus mWTFb infected in simian B95a cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Measles morbillivirus	4		organism-based format	Scientific Literature
4.	ALA2329373	F	Antiviral activity against Measles virus Edmonston infected in simian B95a cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Measles morbillivirus	1		organism-based format	Scientific Literature
5.	ALA2329374	F	Antiviral activity against HSV 2 NCPV 132349 infected in african green monkey BSC-1 cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Human alphaherpesvirus 2	1		organism-based format	Scientific Literature
6.	ALA2329375	F	Antiviral activity against HSV 2 NCPV 132349 infected in human HFFF cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Human alphaherpesvirus 2	1		organism-based format	Scientific Literature
7.	ALA2329376	F	Antiviral activity against HSV 1 NCPV 17+ infected in african green monkey BSC-1 cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Human alphaherpesvirus 1	1		organism-based format	Scientific Literature
8.	ALA2329377	F	Antiviral activity against HSV 1 NCPV 17+ infected in human HFFF cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Human alphaherpesvirus 1	1		organism-based format	Scientific Literature
9.	ALA2329378	F	Antiviral activity against Measles virus Edmonston infected in african green monkey BSC-1 cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Measles morbillivirus	1		organism-based format	Scientific Literature
10.	ALA2329379	F	Antiviral activity against Adenovirus type 5 ATCC VR-5 infected in african green monkey BSC1 cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Human adenovirus 5	1		organism-based format	Scientific Literature
11.	ALA2329380	F	Antiviral activity against Adenovirus type 5 ATCC VR-5 infected in human HFFF cells assessed as virus-induced cytopathogenicity incubated for 30 mins prior to inoculation measured after 3 days by phase contrast microscopy	Human adenovirus 5	1		organism-based format	Scientific Literature
12.	ALA2329381	A	Cytotoxicity against african green monkey BSC1 cells infected with Vaccinia virus-WR after 4 days	Chlorocebus aethiops	8		cell-based format	Scientific Literature
13.	ALA2329382	A	Cytotoxicity against african green monkey BSC1 cells infected with Vaccinia virus-WR luciferase reporter virus v3 assessed as visible cytotoxic effect at 10 uM incubated for 30 mins prior to inoculation measured after 2 hrs by phase contrast microscopic analysis	Chlorocebus aethiops	21		cell-based format	Scientific Literature
14.	ALA2329383	F	Selectivity index, ratio of CC50 for african green monkey BSC1 cells to IC50 for Vaccinia virus-WR		1		cell-based format	Scientific Literature
15.	ALA2329384	A	Cytotoxicity against human HFFF cells assessed as cell viability by CellTitre-Glo Luminescent Cell Viability assay	Homo sapiens	6		cell-based format	Scientific Literature
16.	ALA2329385	A	Cytotoxicity against african green monkey BSC1 cells assessed as ATP levels after 4 days by CellTitre-Glo Luminescent Cell Viability assay	Chlorocebus aethiops	6		cell-based format	Scientific Literature
17.	ALA2329386	F	Antiviral activity against Vaccinia virus WR infected in african green monkey BSC1 cells after 4 days by plaque reduction assay	Vaccinia virus	9		organism-based format	Scientific Literature
18.	ALA2329387	F	Antiviral activity against Vaccinia virus WR expressing luciferase reporter virus v3 infected in rabbit RK13 cells assessed as inhibition of early stages of VACV replication at 10 uM incubated for 30 mins prior to inoculation measured after 2 hrs by luciferase reporter gene assay relative to control	Vaccinia virus	22		organism-based format	Scientific Literature